Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryCRO

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2044610

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2044610

Pharmaceutical Contract Manufacturing Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global Pharmaceutical Contract Manufacturing Market is gaining strong momentum as pharmaceutical and biotechnology companies increasingly depend on external manufacturing partners to improve efficiency, reduce capital burden, and accelerate product launches. The market is valued at US$ 156.9 Bn in 2026 and is projected to reach US$ 311.2 Bn by 2033, growing at a CAGR of 10.30% during the forecast period. Contract manufacturing has become a critical part of the pharmaceutical value chain, supporting companies across drug development, commercial-scale production, biologics manufacturing, packaging, labelling, and fill-finish services. As drug pipelines become more complex and global demand for medicines continues to rise, contract manufacturing organizations are expected to play a larger role in ensuring scalable, compliant, and cost-effective production.

Market Insights

The Pharmaceutical Contract Manufacturing Market is expanding due to the growing need for specialized manufacturing capabilities across small molecules, large molecules, sterile injectables, and biologics. Pharmaceutical companies are increasingly outsourcing production to access advanced facilities, technical expertise, and regulatory-ready infrastructure without investing heavily in internal capacity. This shift is especially important for companies managing multiple product pipelines, patent expiries, generic competition, and rising demand from emerging markets. Contract manufacturers help drug developers manage production complexity while maintaining quality standards and supply reliability. Their services are no longer limited to basic manufacturing; they now include formulation support, technology transfer, process optimization, analytical services, packaging, and lifecycle management.

Drivers

One of the key drivers of the market is the increasing pressure on pharmaceutical companies to shorten development and commercialization timelines. Outsourcing allows companies to focus on core competencies such as research, clinical development, regulatory strategy, and market expansion while experienced partners handle manufacturing operations. Rising demand for biologics and biosimilars is also boosting the need for specialized contract manufacturing services, as these products require advanced production systems, controlled environments, and highly skilled technical teams. In addition, the growing burden of chronic diseases, expanding access to healthcare, and increasing demand for affordable generic medicines are encouraging companies to partner with contract manufacturers that can deliver scale, flexibility, and cost advantages.

Business Opportunity

The market presents significant opportunities for contract manufacturers offering integrated services from early-stage development to commercial supply. Pharmaceutical companies increasingly prefer partners that can manage multiple stages of the product lifecycle, including drug development services, manufacturing, packaging, labelling, and fill-finish operations. Providers with expertise in biologics manufacturing, sterile processing, high-potency drugs, and complex formulations are well positioned to capture future demand. There is also strong opportunity in serving small and medium-sized pharmaceutical companies and biotech firms that may not have the infrastructure required for large-scale production. As outsourcing becomes more strategic, contract manufacturers that invest in automation, digital quality systems, capacity expansion, and global regulatory capabilities are expected to gain a competitive advantage.

Region Analysis

North America holds a prominent position in the Pharmaceutical Contract Manufacturing Market due to its strong pharmaceutical industry, advanced research ecosystem, high outsourcing adoption, and demand for specialized biologics and injectable manufacturing. Europe remains an important market, supported by established pharmaceutical companies, strong regulatory standards, and growing demand for high-quality manufacturing and packaging services. Asia Pacific is witnessing rapid growth as the region offers cost-effective production, expanding manufacturing infrastructure, skilled workforce availability, and increasing investments in pharmaceutical capabilities. The region is becoming a major hub for generic drug production, active pharmaceutical ingredient manufacturing, biologics development, and contract research-linked manufacturing services. South America and the Middle East and Africa are also expected to see gradual growth as healthcare access improves, local pharmaceutical production expands, and companies seek regional supply chain resilience.

Key Players

The Pharmaceutical Contract Manufacturing Market is competitive, with leading companies focusing on capacity expansion, technology upgrades, strategic partnerships, and specialized service portfolios. Key players operating in the market include:

  • Lonza Group
  • Thermo Fisher Scientific Inc. / Patheon
  • Catalent, Inc.
  • Samsung Biologics
  • WuXi AppTec
  • WuXi Biologics
  • Recipharm AB
  • Fareva Group
  • Piramal Pharma Solutions
  • Curia Global, Inc.
  • Syngene International Ltd.
  • AGC Biologics
  • Vetter Pharma International GmbH
  • Almac Group
  • Fujifilm Diosynth Biotechnologies

These companies are strengthening their market presence by expanding biologics capacity, improving sterile manufacturing capabilities, enhancing quality systems, and supporting global pharmaceutical clients with end-to-end solutions. Their ability to meet strict regulatory requirements, ensure supply continuity, and support complex product categories will remain essential for long-term growth.

Segmentation

By Services:

  • Pharmaceutical Manufacturing Services
  • Drug Development Services
  • Biologics Manufacturing Services
  • Packaging & Labelling Services
  • Fill-finish Services
  • Other Services

By Molecules:

  • Small molecules
  • Large Molecules

By end users:

  • Big pharmaceutical companies
  • Small & medium-sized pharmaceutical companies
  • Generic pharmaceutical companies
  • Others (Academic Institutes CROs)

Regions Covered:

  • North America
  • Asia Pacific
  • Europe
  • South America
  • Middle East and Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Pharmaceutical Contract Manufacturing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Pharmaceutical Contract Manufacturing Market Outlook, 2020 - 2033

  • 3.1. Global Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Pharmaceutical Manufacturing Services
    • 3.1.2. Drug Development Services
    • 3.1.3. Biologics Manufacturing Services
    • 3.1.4. Packaging & Labelling Services
    • 3.1.5. Fill-finish Services
    • 3.1.6. Other Services
  • 3.2. Global Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033
    • 3.2.1. Small molecules
    • 3.2.2. Large Molecules
  • 3.3. Global Pharmaceutical Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.3.1. Big pharmaceutical companies
    • 3.3.2. Small & medium-sized pharmaceutical companies
    • 3.3.3. Generic pharmaceutical companies
    • 3.3.4. Others (Academic Institutes CROs)
  • 3.4. Global Pharmaceutical Contract Manufacturing Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Pharmaceutical Contract Manufacturing Market Outlook, 2020 - 2033

  • 4.1. North America Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Pharmaceutical Manufacturing Services
    • 4.1.2. Drug Development Services
    • 4.1.3. Biologics Manufacturing Services
    • 4.1.4. Packaging & Labelling Services
    • 4.1.5. Fill-finish Services
    • 4.1.6. Other Services
  • 4.2. North America Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033
    • 4.2.1. Small molecules
    • 4.2.2. Large Molecules
  • 4.3. North America Pharmaceutical Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.3.1. Big pharmaceutical companies
    • 4.3.2. Small & medium-sized pharmaceutical companies
    • 4.3.3. Generic pharmaceutical companies
    • 4.3.4. Others (Academic Institutes CROs)
  • 4.4. North America Pharmaceutical Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 4.4.2. U.S. Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 4.4.3. U.S. Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 4.4.4. Canada Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 4.4.5. Canada Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 4.4.6. Canada Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Pharmaceutical Contract Manufacturing Market Outlook, 2020 - 2033

  • 5.1. Europe Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Pharmaceutical Manufacturing Services
    • 5.1.2. Drug Development Services
    • 5.1.3. Biologics Manufacturing Services
    • 5.1.4. Packaging & Labelling Services
    • 5.1.5. Fill-finish Services
    • 5.1.6. Other Services
  • 5.2. Europe Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033
    • 5.2.1. Small molecules
    • 5.2.2. Large Molecules
  • 5.3. Europe Pharmaceutical Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.3.1. Big pharmaceutical companies
    • 5.3.2. Small & medium-sized pharmaceutical companies
    • 5.3.3. Generic pharmaceutical companies
    • 5.3.4. Others (Academic Institutes CROs)
  • 5.4. Europe Pharmaceutical Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 5.4.2. Germany Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 5.4.3. Germany Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 5.4.4. Italy Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 5.4.5. Italy Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 5.4.6. Italy Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 5.4.7. France Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 5.4.8. France Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 5.4.9. France Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 5.4.10. U.K. Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 5.4.11. U.K. Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 5.4.12. U.K. Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 5.4.13. Spain Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 5.4.14. Spain Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 5.4.15. Spain Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 5.4.16. Russia Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 5.4.17. Russia Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 5.4.18. Russia Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 5.4.19. Rest of Europe Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 5.4.20. Rest of Europe Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 5.4.21. Rest of Europe Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Pharmaceutical Manufacturing Services
    • 6.1.2. Drug Development Services
    • 6.1.3. Biologics Manufacturing Services
    • 6.1.4. Packaging & Labelling Services
    • 6.1.5. Fill-finish Services
    • 6.1.6. Other Services
  • 6.2. Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033
    • 6.2.1. Small molecules
    • 6.2.2. Large Molecules
  • 6.3. Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.3.1. Big pharmaceutical companies
    • 6.3.2. Small & medium-sized pharmaceutical companies
    • 6.3.3. Generic pharmaceutical companies
    • 6.3.4. Others (Academic Institutes CROs)
  • 6.4. Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 6.4.2. China Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 6.4.3. China Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 6.4.4. Japan Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 6.4.5. Japan Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 6.4.6. Japan Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 6.4.7. South Korea Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 6.4.8. South Korea Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 6.4.9. South Korea Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 6.4.10. India Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 6.4.11. India Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 6.4.12. India Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 6.4.13. Southeast Asia Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 6.4.14. Southeast Asia Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 6.4.15. Southeast Asia Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 6.4.16. Rest of SAO Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 6.4.17. Rest of SAO Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 6.4.18. Rest of SAO Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Pharmaceutical Contract Manufacturing Market Outlook, 2020 - 2033

  • 7.1. Latin America Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Pharmaceutical Manufacturing Services
    • 7.1.2. Drug Development Services
    • 7.1.3. Biologics Manufacturing Services
    • 7.1.4. Packaging & Labelling Services
    • 7.1.5. Fill-finish Services
    • 7.1.6. Other Services
  • 7.2. Latin America Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033
    • 7.2.1. Small molecules
    • 7.2.2. Large Molecules
  • 7.3. Latin America Pharmaceutical Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.3.1. Big pharmaceutical companies
    • 7.3.2. Small & medium-sized pharmaceutical companies
    • 7.3.3. Generic pharmaceutical companies
    • 7.3.4. Others (Academic Institutes CROs)
  • 7.4. Latin America Pharmaceutical Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 7.4.2. Brazil Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 7.4.3. Brazil Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 7.4.4. Mexico Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 7.4.5. Mexico Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 7.4.6. Mexico Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 7.4.7. Argentina Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 7.4.8. Argentina Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 7.4.9. Argentina Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 7.4.10. Rest of LATAM Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 7.4.11. Rest of LATAM Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 7.4.12. Rest of LATAM Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Pharmaceutical Manufacturing Services
    • 8.1.2. Drug Development Services
    • 8.1.3. Biologics Manufacturing Services
    • 8.1.4. Packaging & Labelling Services
    • 8.1.5. Fill-finish Services
    • 8.1.6. Other Services
  • 8.2. Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033
    • 8.2.1. Small molecules
    • 8.2.2. Large Molecules
  • 8.3. Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.3.1. Big pharmaceutical companies
    • 8.3.2. Small & medium-sized pharmaceutical companies
    • 8.3.3. Generic pharmaceutical companies
    • 8.3.4. Others (Academic Institutes CROs)
  • 8.4. Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 8.4.2. GCC Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 8.4.3. GCC Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 8.4.4. South Africa Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 8.4.5. South Africa Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 8.4.6. South Africa Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 8.4.7. Egypt Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 8.4.8. Egypt Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 8.4.9. Egypt Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 8.4.10. Nigeria Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 8.4.11. Nigeria Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 8.4.12. Nigeria Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
    • 8.4.13. Rest of Middle East Pharmaceutical Contract Manufacturing Market Outlook, by Service Type, 2020-2033
    • 8.4.14. Rest of Middle East Pharmaceutical Contract Manufacturing Market Outlook, by Molecule Type, 2020-2033
    • 8.4.15. Rest of Middle East Pharmaceutical Contract Manufacturing Market Outlook, by End User, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Lonza Group
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Thermo Fisher Scientific Inc. / Patheon
    • 9.4.3. Catalent, Inc.
    • 9.4.4. Samsung Biologics
    • 9.4.5. WuXi AppTec
    • 9.4.6. WuXi Biologics
    • 9.4.7. Recipharm AB
    • 9.4.8. Fareva Group
    • 9.4.9. Piramal Pharma Solutions
    • 9.4.10. Curia Global, Inc.
    • 9.4.11. Syngene International Ltd.
    • 9.4.12. AGC Biologics
    • 9.4.13. Vetter Pharma International GmbH
    • 9.4.14. Almac Group
    • 9.4.15. Fujifilm Diosynth Biotechnologies

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!